Drug Recall

 

HPS Pharmacies wish to advise that LINK Healthcare, in consultation with the Therapeutic Goods Administration (TGA), have given notice of an urgent drug recall of:

Neo-Mercazole® 5mg Tablets x 100
(carbimazole)
Batch Numbers: F2001, F2002, F2004

This recall has been issued due to the identification of foreign matter in batch number F2001. Batches F220 and F2004 have been included in the recall in the interest of patient safety.

LINK Healthcare currently distribute both Neo-Mercazole® and Carbimazole ARISTO® tablets under Section 19(A) of the Therapeutic Goods Act, which permits supply of an unregistered product in situations where there is an interruption to supply of a registered product for which there is a recognised medical need.

This recall encompasses all supplies of Neo-Mercazole® tablets currently in circulation, however there are no concerns regarding safety or continuity of supply of Carbimazole ARISTO® tablets.

Please inspect your stocks and quarantine all units of the above batches of Neo-Mercazole® tablets for return to your supplier. Any items supplied by HPS Pharmacies should be returned to the pharmacy for processing.

Retain this notice in a prominent position, including in other related business units until normal supply resumes. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or LINK Healthcare on 1800 181 060.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates